Abstract
Objective
To catalog and characterize the proteome of normal human intervertebral disc (IVD).
Methods
Nine magnetic resonance imaging (MRI) normal IVDs were harvested from 9 different brain dead yet alive voluntary organ donors and were subjected to electrospray ionization-liquid chromatography tandem mass spectrometry (ESI-LC-MS/MS) acquisition.
Results
A total of 1,116 proteins were identified. Functional enrichment analysis tool DAVID ver. 6.8 categorized: extracellular proteins (38%), intracellular (31%), protein-containing complex (13%), organelle (9%), membrane proteins (6%), supramolecular complex (2%), and 1% in the cell junction. Molecular function revealed: binding activity (42%), catalytic activity (31%), regulatory activity (14%), and structural activity (7%). Molecular transducer, transporter, and transcription regulator activity together contributed to 6%. A comparison of the proteins obtained from this study to others in the literature showed a wide variation in content with only 3% of bovine, 5% of murine, 54% of human scoliotic discs, and 10.2% of discs adjacent to lumbar burst fractures common to our study of organ donors. Between proteins reported in scoliosis and lumbar fracture patients, only 13.51% were common, further signifying the contrast amongst the various MRI normal IVD samples.
Conclusion
The proteome of “healthy” human IVDs has been defined, and our results show that proteomic data on IVDs obtained from scoliosis, fracture patients, and cadavers lack normal physiological conditions and should not be used as biological controls despite normal MRI findings. This questions the validity of previous studies that have used such discs as controls for analyzing the pathomechanisms of disc degeneration.
Keywords: Tandem mass spectrometry, Human intervertebral disc, Proteome, Degenerative disc disease, Tissue donors, Gene ontology
INTRODUCTION
Low back pain (LBP) is the most common musculoskeletal disorder affecting 540 million people globally [1]. Lumbar degenerative disc disease (DDD) is the leading cause of LBP and remains poorly understood. During disc degeneration, the intervertebral disc (IVD) undergoes physiological and morphological changes that lead to alterations in the extracellular matrix (ECM). However, to understand the exact differences that occur in the disc proteome during this degenerative process, clear documentation of the proteins expressed in discs under normal physiological conditions is essential.
Characterization of the proteome of a normal IVD has been challenging due to the limited access to appropriate biological samples. To date, many comparative proteomic studies have used disc samples harvested from scoliosis, spinal trauma, and cadavers as controls to analyze diseased IVD as they appear normal in MRI. Control discs obtained from scoliosis subjects are reported to have an asymmetric loading pattern, leading to bone deformity [2], and stress profiles similar to degenerated discs [3], indicating pathomorphological changes that alter the cellular activity. The high-stress levels and asymmetrical loading in these discs might result in an altered biological composition, thus flawing the results of molecular comparative studies that have used these samples as “healthy” controls.
Lumbar spine burst fractures might also not represent actual controls, as 70% of the discs have been reported to have disc edema, bleeding/rupture, or displacement, which provides evidence of alteration in biochemical composition inside the IVD [4]. In an animal study of vertebral endplate damage induced changes in IVD, the elevation of cytotoxic lactate dehydrogenase enzyme, upregulated expression of pro-apoptotic proteins such as FasL and tumor necrosis factor-α, along with increase in catabolic gene expression (matrix metalloproteinase [MMP]-1 and MMP-13) demonstrates that discs procured from spaces adjacent to spinal trauma do not represent physiologically normal conditions [5].
On the other hand, despite many studies stating that the integrity of proteins in autopsy specimens from 6 hours after death remains stable with only a minor degree of loss, hypoxia in these specimens is a critical agonal factor. Extended agonal state and hypoxia will lead to the increase in tissue lactate, thus lowering pH, which plays a significant role in alterations of RNA and protein integrity and may, therefore, fail to reflect homeostasis. Notably, it assumes more importance in a human IVD which is believed to be an avascular tissue and primarily depends on nutrition through solute transport occurring across end plates by the process of diffusion.
The majority of studies in LBP involve in vivo models of other animals such as bovine [6], murine [7], canine [8], porcine, and caprine discs to understand the disease mechanisms in the human nucleus pulposus (NP). However, due to inter-species differences, their value for understanding disc pathology is limited, which emphasizes the need for proper human controls for molecular-level studies.
In this study, 9 MRI normal discs were harvested from brain dead yet alive voluntary asymptomatic organ donors, and we employed proteomic approach coupled with tandem mass spectrometry to derive the comprehensive list of proteins expressed in true biologically healthy control discs which would serve as the basis for identifying the biological processes (BPs) and pathways disrupted during aging and in DDD.
MATERIALS AND METHODS
The study was conducted after the approval of Institutional Review Board (IRB) of Ganga Medical Centre and Hospitals Pvt Ltd. (reference No. 2/2/2018) and samples were processed as per the ethical guidelines of the Indian Council of Medical research. Access to discs from organ donors was through licence obtained from regional organ transplant board for acquiring bone and musculoskeletal tissue.
1. Harvesting the Human IVD Tissues From Brain Dead Organ Donor
Lumbar spine segments were collected under sterile operating conditions as a source of bone allograft from 9 brain dead voluntary organ patients with no history of spinal trauma or spinal disorder after approval from the IRB. The removed spine segments were immediately investigated by plain radiography (Fig. 1A), 1.5 Tesla MRI (Fig. 1B), and computed tomography (Fig. 1C). The harvested segments which were completely normal in imaging (Fig. 2A) were segregated into vertebrae (Fig. 2B), annulus fibrosus, NP (Fig. 2C), and endplates (Fig. 2D) under strict aseptic precautions using microscope. To avoid cells from annulus fibrosus, we chose to dissect NP well short of the transitional zone. The bones were used as a source of allografts after processing them appropriately in a licensed bone bank (Fig. 2B). The remnant MRI normal NP of disc tissues were first washed with phosphate buffer solution (PBS) and stored in Cryovials and then snap-frozen immediately in liquid nitrogen containers. These tissues were carefully transported to the research center for further processing and analysis.
2. Protein Extraction from Human IVD Tissues and Clean-up Prior to In-Gel Prefractionation
Around 200 mg of NP snap-frozen in liquid nitrogen was pulverized and resuspended in 2 mL of radio immunoprecipitation assay buffer (RIPA) buffer (50 mM Tris-Hcl, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS], 1% Triton X-100, 10% glycerol) and vortexed for 30 seconds. Further, the samples were sonicated thrice in pulse mode for 15 seconds on and off with an amplitude of 35%. The sample tubes were kept immersed in an ethanol ice bath throughout the process. The sonicated sample was incubated on ice for 30 minutes and centrifuged at 10,000 rpm for 20 minutes at 4°C. The supernatant contained hydrophilic, and mild hydrophobic proteins were labelled as S1 fraction. The pellet expected to contain membrane and hydrophobic proteins were extracted by adding 1 mL of 2% SDS and the homogenized sample was further boiled at 70°C for 10 minutes. The mixture was centrifuged at 12,000 rpm for 30 minutes at 23°C, and the resultant supernatant was labelled as S2 fraction.
3. Sample Clean-up using an Organic Solvent to Remove the Interfering Glycans From the Proteins before Proteome Analysis Using Tandem Mass Spectrometry
Fractions S1 and S2 obtained for each sample were cleaned up using organic solvent chloroform: methanol: water in the ratio 1:4:1:3 (v/v) (1 volume of the sample; 4 volumes of methanol: 1 volume of chloroform and 3 volumes of water) and vortexed for 30 seconds twice. The mixture was centrifuged at 10,000 rpm for 20 minutes at 4°C. The chloroform layer containing the protein was removed, and an equal volume of methanol was added and centrifuged at 10,000 rpm for 20 minutes at 4°C. The resulting pellet was rinsed twice with methanol and centrifuged with the same parameters as specified above. The resulting pellet is so fragile; hence the methanol should be discarded with caution without disturbing the pellet, which is further air-dried for 3 minutes and resuspended in 200 µL of 10 mM Tris-HCl 8.0, 0.1% SDS.
Fifty micrograms of the total proteins were then prefractionated in 10% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and stained with colloidal coomassie brilliant blue G250.
4. Tryptic Digestion, Peptide Extraction, and Purification Using C18 Spin Columns
The total proteins of the human IVD were subjected to tryptic in-gel digestion, followed by the analysis of the tryptic peptides using tandem mass spectrometry.
The entire lane was sliced into 10 fractions and subjected to tryptic digestion at a concentration of 600 ng/fraction. The tryptic peptides were purified using C18 columns (Agilent Peptide Cleanup C18 Spin Column [#Cat No. 51882750]) before mass spectrometry as per the manufacturer’s instruction. Each of the 3 fractions was pooled, dried, and resuspended in an appropriate volume of 0.1% formic acid with 5% acetonitrile. Around 1,000 fmol (femtomole) of the tryptic peptides from each fraction were loaded to nano-liquid chromatography (LC) and subjected to tandem mass acquisition. The resultant raw files from the electrospray ionization-liquid chromatography tandem mass spectrometry (ESI-LC-MS/MS) were processed in PD ver. 1.4, as described in the (Fig. 3).
5. Relative Quantification by Spectral Count
Spectral counts obtained by LC/MS-MS were further subjected to normalization by normalized spectral abundance factor (NSAF) method [9].
6. Gene Ontology and Pathway Enrichment Analysis
To interpret the functional enrichment of healthy IVD proteins, gene ontology (GO), including BP, molecular function (MF), and cellular component (CC), was performed using ‘cluster profiler’ in R vs. 3.6.1 (2019-07-05) (R Foundation, Vienna, Austria) program. Besides, pathway enrichment analysis was performed using the Reactome database.
7. Clustering and Protein-Protein Interaction Network
The identified proteins were mapped using the Search Tool for the Retrieval of Interacting Genes (STRING; http://string-db.org) with default settings, and the disconnected nodes were excluded from the interaction analysis. Protein Interaction Network (PPI) network with the interaction score > 0.4 was extracted from STRING, and the network was further analyzed using Cytoscape cytoHubba [10]. Top 10 ranked proteins were identified using cytoHubba plugin based on one of the important network scoring methods: Degree. Proteins with higher degrees are considered to be more essential proteins.
8. Histology and Immunohistochemistry
Among 9 IVD NP tissues collected for the study, only 2 were subjected to Immunohistochemical (IHC) analysis. IHC validation of the proteomic findings was performed by indirect 3-step immunoperoxidase-technique with an avidin-biotin complex (ABC) detection system (paraffin). Lumbar spines were fixed in 4% paraformaldehyde overnight at 4°C, decalcified at room temperature, dehydrated in ethanol, washed with xylene, and embedded in paraffin. Tissues sections were cut at a thickness of 5–6 µm using a microtome (Leica Microsystems, Wetzlar, Germany) with overnight incubation at 37°C, deparaffinized in xylene, dehydrated in ethanol, and incubated with 0.3% hydrogen peroxide in absolute methanol for 20 minutes at room temperature to inhibit endogenous peroxidase activity. Then sections were re-hydrated with 96% alcohol, followed by 70% ethanol for 10 minutes and double distilled water for 3 times. To eliminate chemical modifications, antigen retrieval was performed and incubated overnight with a 1% primary antibody in bovine serum albumin in PBS. Followed PBS wash, sections were subjected to incubation with biotinylated secondary antibody for 60 minutes and washed with PBS for 3 times, 5 minutes each before incubating for 30 minutes with horseradish peroxidase labeled ABC complex. The colored reaction product was developed with 3, 3-diaminobenzidine tetrahydrochloride. Finally, the sections were counterstained lightly with hematoxylin for microscopic examination of the antigen-antibody complex.
9. Data Submission
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD016560 and 10.6019/PXD016560.
RESULTS
A total of 1,116 different proteins were identified, and the results are discussed as per the protocols followed to ensure the maximal retrieval of proteins along with the findings of the various methods employed before optimization.
1. Enrichment of ECM Proteins From NP Tissues
The ECM proteins are large, diverse molecules with high interconnectivity, which makes them insoluble in low concentration of salts and detergents. In this study, we tried to extract the ECM proteins with various buffers (1X laemelli, 2% SDS, guanidium-HCl, Tris-acetate Nacl, and RIPA) with different composition and found sequential extraction with 22 different buffers: RIPA followed by 2% SDS was found to yield better prefractionation profile in 10% SDS-PAGE as observed in (Supplementary Fig. 1A).
Following sequential enrichment, the interference of the high concentration of glycosaminoglycans (GAGs) in the protein prefractionation on SDS-PAGE was a significant challenge. The interfering GAGs, salts, detergents were precipitated using: acetone; ethanol; tricholoroacetic acid (TCA)-acetone; 3kDa membrane cutoff device and methanol-chloroform. A broadening of lanes was observed with the use of ethanol and 3kDa cutoff device, showing the inefficiency of the methods to remove salts. Similarly, acetone precipitation failed to remove the interfering GAGs (Supplementary Fig. 1B). TCA-acetone precipitation shows the loss of proteins, especially around the 66-kDa region (circled in Fig. 4B).
Interestingly the prominent 67-kDa protein was completely TCA soluble. Out of these, methanol-chloroform was found to be efficient as shown (Supplementary Fig. 1B) in terms of removal of glycans, salts and detergents, and the recovery of the total protein (Table 1) was close to 62%. Supplementary Fig. 2A illustrates the efficiency of a sample clean-up by methanol-chloroform with that of acetone, and 3-kDa membrane cutoff device.
Table 1.
Solvents | Initial concentration | Final concentration | % Loss | % Gain |
---|---|---|---|---|
Methanol-chloroform | 100 | 62 | 38 | 62 |
Ethanol | 100 | 65 | 35 | 65 |
Acetone | 100 | 83 | 17 | 83 |
TCA-acetone | 100 | 43.7 | 56.3 | 43.7 |
3-kDa cutoff device | 100 | 51.6 | 48.4 | 51.6 |
TCA, tricholoroacetic acid.
Following sample clean-up with methanol-chloroform and prefractionation on 10% SDS-PAGE, the functional annotation for BP in the samples revealed proteins involved in complementary activation, positive regulation of inflammatory response, and inflammatory response proteins (Supplementary Fig. 2B) which failed to show up before sample clean-up. This indicates the importance of sample clean-up in detecting proteins of low abundance, which might be of clinical significance.
2. Identification of NP Related Proteomic Signatures by 1D Gel Analysis
We deployed shotgun proteomics to determine the total proteins in healthy IVD tissues of 9 organ donor samples by using LC-MS/MS analysis. A total of 1,116 proteins were identified, and the identified proteins’ accessions and their peptides were verified against the Uniprot database (2018). Uncharacterized or putative or fragment proteins were excluded, and they are documented in Supplementary Table 1.
The entire matrisome list of normal IVD was created by comparing it with the matrisome database (http://matrisome.org/). The quantitative analysis based on their peptide spectral matches (PSM) revealed that normal NP proteome consisted of 57% of matrisomal proteins (core matrisome, regulators, ECM affiliated, and secreted factors) and 43% of other proteins (cytoskeletal proteins, intracellular proteins, membrane proteins, and blood components). The matrisome further consisted of 90% of core matrisomal proteins and 10% of matrisome-associated proteins (Fig. 4). The core matrisome was further characterized as proteoglycans (80%), glycoproteins (17%), and collagens (3%). The matrisome-associated proteins were categorized as ECM regulators (86%), ECM-affiliated (11%), secreted proteins (3%). The quantitative distribution of the proteins is illustrated in Fig. 4.
3. GO Analysis
A cutoff PSM ≥ 5 was applied to the total proteins identified to increase the confidentiality of the GO process. With this filter, 242 of 1,116 proteins were considered for GO enrichment analysis under BPs, MF, and CC using cluster profiler in R ver. 3.6.1 (2019-07-05). The overall spread of GO that was all significantly enriched is depicted in Fig. 5.
In BP, the majority of the proteins were associated with the ECM and structural organization along with other metabolic processes that involve keratinization, cell differentiation, complement activation, collagen fibril organization, and cornification whereas in MF proteins were associated with structural constitution and resistance of matrix compression. As expected, in the CC category, proteins expressed were related to the ECM followed by the membrane and cytoplasmic regions.
4. Pathway Enrichment Analysis
Pathway analysis was performed with 242 proteins using the STRING database, and a total of 105 significant pathways were found to be enriched (Supplementary Table 2). Out of these, pathways required for IVD homeostasis were found to be highly significant (p < 0.05). Pathway enrichment revealed that most of the glycoproteins and proteoglycans were involved in ECM organization pathways. Collagens and glycoproteins identified were involved in activation of the Collagen biosynthesis, collagen chain trimerization, and integrin cell surface interaction pathways. ECM glycoproteins, collagens, and proteoglycans were a part of nonintegrin membrane-ECM interactions and carbohydrate metabolism. Cytoskeletal proteins were observed in the formation of the cornified envelope pathways, developmental biology, and Keratan Sulfate Biosynthesis. These pathways along with their genes, are enlisted in (Table 2). While the most significantly enriched pathway was the formation of a cornified envelope ECM organization, it was interesting to observe that the maximum number of proteins was involved in the immune system pathways followed by ECM organization.
Table 2.
No. | Enriched pathway | Proteins involved | p-value | Gene symbol | |
---|---|---|---|---|---|
Based on p-value | |||||
1 | Formation of the cornified envelope | 29 | 1.66E-24 | CDSN, DSG1, DSP, JUP, KRT1, KRT10, KRT14, KRT15, KRT16, KRT17, KRT19, KRT2, KRT33A, KRT4, KRT5, KRT6A, KRT6B, KRT6C, KRT72, KRT73, KRT76, KRT77, KRT78, KRT79, KRT8, KRT80, KRT84, KRT9, TGM5 | |
2 | Extracellular matrix organization | 37 | 8.90E-24 | A2M, ACAN, ASPN, BGN, CD47, COL10A1, COL11A2, COL14A1, COL15A1, COL1A1, COL1A2, COL2A1, COL6A1, COL6A2, COL6A3, COMP, DCN, FGA, FGB, FGG, FMOD, GDF5, HAPLN1, HSPG2, HTRA1, LOX, LUM, MMP10, PCOLCE, PCOLCE2, PPIB, THBS1, TIMP1, TNC, TTR, VCAN, VTN | |
3 | Platelet degranulation | 22 | 1.04E-16 | A1BG, A2M, ALB, ANXA5, APOA1, CD109, CLEC3B, CLU, F13A1, FGA, FGB, FGG, HRG, ITIH4, QSOX1, SERPINA1, SERPING1, TF, THBS1, TIMP1, TIMP3, TTN | |
4 | ECM proteoglycans | 18 | 9.26E-16 | ACAN, ASPN, BGN, COL1A1, COL1A2, COL2A1, COL6A1, COL6A2, COL6A3, COMP, DCN, FMOD, HAPLN1, HSPG2, LUM, TNC, VCAN, VTN | |
5 | Integrin cell surface interactions | 17 | 6.49E-14 | CD47, COL10A1, COL1A1, COL1A2, COL2A1, COL6A1, COL6A2, COL6A3, COMP, FGA, FGB, FGG, HSPG2, LUM, THBS1, TNC, VTN | |
6 | Platelet activation, signaling and aggregation | 25 | 6.50E-14 | A1BG, A2M, ALB, ANXA5, APOA1, CD109, CLEC3B, CLU, COL1A1, COL1A2, F13A1, FGA, FGB, FGG, HRG, ITIH4, QSOX1, RASGRP2, SERPINA1, SERPING1, TF, THBS1, TIMP1, TIMP3, TTN | |
7 | Innate immune system | 45 | 2.71E-13 | A1BG, ACTG1, ANXA2, ARG1, C1S, C3, C9, CALML5, CASP8, CD47, CFB, CFI, CHI3L1, CLU, DCD, DSG1, DSP, FABP5, FGA, FGB, FGG, FLG2, FTL, GSN, HBB, HP, HRNR, JUP, KRT1, LTF, LYZ, MIF, PKM, PLA2G2A, QSOX1, RASGRP2, S100A1, S100A8, S100A9, SERPINA1, SERPINB1, SERPING1, TNFAIP6, TTR, VTN | |
8 | Hemostasis | 34 | 1.31E-12 | A1BG, A2M, ALB, ANXA2, ANXA5, APOA1, CD109, CD47, CLEC3B, CLU, COL1A1, COL1A2, F13A1, FGA, FGB, FGG, HBB, HBD, HRG, ITIH4, KIF1B, MIF, QSOX1, RASGRP2, SERPINA1, SERPINA5, SERPINC1, SERPINE2, SERPING1, TF, THBS1, TIMP1, TIMP3, TTN | |
9 | Neutrophil degranulation | 29 | 1.53E-11 | A1BG, ANXA2, ARG1, C3, CALML5, CD47, CHI3L1, DSG1, DSP, FABP5, FLG2, FTL, GSN, HBB, HP, HRNR, JUP, KRT1, LTF, LYZ, MIF, PKM, QSOX1, S100A8, S100A9, SERPINA1, SERPINB1, TNFAIP6, TTR | |
10 | Degradation of the extracellular matrix | 17 | 7.17E-11 | A2M, ACAN, COL10A1, COL11A2, COL14A1, COL15A1,COL1A1, COL1A2, COL2A1, COL6A1, COL6A2, COL6A3, DCN, HSPG2, HTRA1, MMP10, TIMP1 | |
Based on number of proteins involved | |||||
1 | Immune system | 57 | 3.58E-10 | A1BG, ACTG1, ANXA1, ANXA2, ARG1, BLMH, C1S, C3, C9, CA1, CALML5, CASP8, CD47, CFB, CFI, CHI3L1, CLU, COL1A1, COL1A2, COL2A1, CSF3R, DCD, DSG1, DSP, F13A1, FABP5, FGA, FGB, FGG, FLG2, FTL, GSN, HBB, HP, HRNR, JUP, KRT1, LTF, LYZ, MIF, MSN, PKM, PLA2G2A, QSOX1, RASGRP2, S100A1, S100A8, S100A9, SERPINA1, SERPINB1, SERPING1, TIMP1, TNFAIP6, TNFRSF11B, TTR, VIM, VTN | |
2 | Innate immune system | 45 | 2.71E-13 | A1BG, ACTG1, ANXA2, ARG1, C1S, C3, C9, CALML5, CASP8, CD47, CFB, CFI, CHI3L1, CLU, DCD, DSG1, DSP, FABP5, FGA, FGB, FGG, FLG2, FTL, GSN, HBB, HP, HRNR, JUP, KRT1, LTF, LYZ, MIF, PKM, PLA2G2A, QSOX1, RASGRP2, S100A1, S100A8, S100A9, SERPINA1, SERPINB1, SERPING1, TNFAIP6, TTR, VTN | |
3 | Extracellular matrix organization | 37 | 8.90E-24 | A2M, ACAN, ASPN, BGN, CD47, COL10A1, COL11A2, COL14A1, COL15A1, COL1A1, COL1A2, COL2A1, COL6A1, COL6A2, COL6A3, COMP, DCN, FGA, FGB, FGG, FMOD, GDF5, HAPLN1, HSPG2, HTRA1, LOX, LUM, MMP10, PCOLCE, PCOLCE2, PPIB, THBS1, TIMP1, TNC, TTR, VCAN, VTN | |
Based on number of proteins involved | |||||
4 | Developmental biology | 37 | 1.28E-08 | ACTG1, ANK2, CDSN, COL2A1, COL6A1, COL6A2, COL6A3, DSG1, DSP, H2AFV, JUP, KRT1, KRT10, KRT14, KRT15, KRT16, KRT17, KRT19, KRT2, KRT33A, KRT4, KRT5, KRT6A, KRT6B, KRT6C, KRT72, KRT73, KRT76, KRT77, KRT78, KRT79, KRT8, KRT80, KRT84, KRT9, MSN, TGM5 | |
5 | Hemostasis | 34 | 1.31E-12 | A1BG, A2M, ALB, ANXA2, ANXA5, APOA1, CD109, CD47, CLEC3B, CLU, COL1A1, COL1A2, F13A1, FGA, FGB, FGG, HBB, HBD, HRG, ITIH4, KIF1B, MIF, QSOX1, RASGRP2, SERPINA1, SERPINA5, SERPINC1, SERPINE2, SERPING1, TF, THBS1, TIMP1, TIMP3, TTN | |
6 | Formation of the cornified envelope | 29 | 1.66E-24 | CDSN, DSG1, DSP, JUP, KRT1, KRT10, KRT14, KRT15, KRT16, KRT17, KRT19, KRT2, KRT33A, KRT4, KRT5, KRT6A, KRT6B, KRT6C, KRT72, KRT73, KRT76, KRT77, KRT78, KRT79, KRT8, KRT80, KRT84, KRT9, TGM5 | |
7 | Neutrophil degranulation | 29 | 1.53E-11 | A1BG, ANXA2, ARG1, C3, CALML5, CD47, CHI3L1, DSG1, DSP, FABP5, FLG2, FTL, GSN, HBB, HP, HRNR, JUP, KRT1, LTF, LYZ, MIF, PKM, QSOX1, S100A8, S100A9, SERPINA1, SERPINB1, TNFAIP6, TTR | |
8 | Platelet activation, signaling and aggregation | 25 | 6.50E-14 | A1BG, A2M, ALB, ANXA5, APOA1, CD109, CLEC3B, CLU, COL1A1, COL1A2, F13A1, FGA, FGB, FGG, HRG, ITIH4, QSOX1, RASGRP2, SERPINA1, SERPING1, TF, THBS1, TIMP1, TIMP3, TTN | |
9 | Disease | 24 | 0.0039 | ACAN, ACTG1, ALB, BGN, CP, DCN, FGA, FGB, FGG, FMOD, HSPG2, IPO5, LTF, LUM, OGN, OMD, PRDX1, PRDX2, PRELP, RBP4, THBS1, TTR, VCAN, YWHAE | |
10 | Platelet degranulation | 22 | 1.04E-16 | A1BG, A2M, ALB, ANXA5, APOA1, CD109, CLEC3B, CLU, F13A1, FGA, FGB, FGG, HRG, ITIH4, QSOX1, SERPINA1, SERPING1, TF, THBS1, TIMP1, TIMP3, TTN |
5. Cluster Analysis and PPI Networks
The filtered proteins were clustered into 5 main categories with high interactions: collagens, cytoskeletons, proteoglycans, glycoproteins, and serine protease inhibitors (SERPINs) (Fig. 6). The total PPI network obtained from STRING comprised 221 connected nodes and 325 edges with an enrichment p-value of < 1.0e-16.
Top 10 ranked hub proteins were predicted using cytohubba based on 3 crucial network topological parameters: degree, maximum neighborhood component (MNC), and closeness (Fig. 7A, B). From both degree and MNC parameters, the top 10 proteins ranked in the following order: ALB (albumin), FN1 (glycoprotein), GAPDH (glycolytic pathway enzyme), TIMP1 (ECM regulators), HP (haptoglobin), C3 (complement), COL1A1, APOA1 (lipoprotein), VTN (vitronectin, glycoprotein), and CLU (clusterin). Based on closeness, we observe the same order of proteins as above except SERPINA1 (ECM regulators) and ceruloplasmin instead of APOA1 and CLU.
Comparative analysis between organ donor IVD proteins obtained in this study with reported proteome literature: (1) other species (murine, ovine, and bovine); (2) scoliosis; and (3) lumbar spines burst fracture patients.
We performed a literature survey to compare our results with existing candidate proteins associated with IVD reported by transcriptional profiling and protein localization studies in bovine and murine (Supplementary Table 1) [11-19]. The comparison showed 24 proteins common to human and bovine and 57 proteins common to human and murine (Fig. 8A). The percentage/number of total proteins may be varied since the comparison was made irrespective of met hodology.
Similarly, we found 60 proteins from our study to be in common to scoliosis and 51 proteins common to lumbar spine burst fracture discs, as reported in the literature (Fig. 8B). Another important finding is that between the reported 111 proteins from scoliosis control discs [20] and 692 proteins lumbar burst spine fracture control discs [21], only 15 proteins were common (Supplementary Table 3).
6. IHC Evaluation
IHC analysis was performed to evaluate the localization and expression of a subset of IVD proteins found in our study. Both lumbar spinal NP tissues subjected to IHC analysis showed positive staining against collagen type II, fibromodulin (FMOD), serine protease inhibitor (SERPINA1), and SERPINE2 (Fig. 9). Type II collagen was found throughout the matrix reconfirming the normalcy of adult discs. We found more pronounced staining of FMOD in cytoplasmic regions, whereas SERPINA1 and SERPINE2 along with cytoplasm as well as nuclear areas. As expected, all the proteins were found much localized to the matrix regions.
DISCUSSION
This study is the first to document the exact proteome profiling of adult NP of MRI normal IVDs, harvested from brain dead yet alive organ donors without history LBP. We employed an in-gel-based proteomic approach coupled with tandem mass spectrometry, and identified a total of 1,116 different proteins and have characterized the proteome of adult NP.
Two significant challenges that exist in the application of proteomics in human IVD include (1) identification of the normal IVD proteome and (2) optimization of appropriate methodology for maximal extraction of proteins from the complex cartilage tissues.
1. Normal IVD Proteome
While blood samples have been accessed from healthy volunteers to define the normal plasma proteome, the harvest of normal IVDs from asymptomatic individuals is unethical and impossible, leaving behind a vast lacuna in the literature on what constitutes a normal disc proteome. Previously, many authors have tried to address this problem by harvesting IVDs from patients undergoing surgery for scoliosis and trauma, and some have done studies on cadaveric discs also. Though they appear normal in MRI, at the molecular level, they might not be accurate biological controls due to altered mechanical stress levels and remodeling secondary to uneven/asymmetric loading in scoliosis and endplate damage or inflammation in discs adjacent to fractures. In this study, we have characterized the proteome of adult human NP by analysing 9 IVDs harvested from brain dead yet alive organ donors which showed each sample id positively correlated with each other and also compared it with the reported proteome of discs obtained from patients with scoliosis and lumbar fractures. A vast variability of the proteome of scoliotic and lumbar fractured samples when compared to the normal proteome of our data, again stresses the fact that they might not be appropriate biological controls. All the samples analysed in our study showed positive correlation with each other (Fig. 10).
2. Optimization of Appropriate Methodology
Standardization of proteomic experiment methodology is essential for reproducibility results in experiments and requires the selection of proper buffer solutions and clean-up agents. Optimal buffer conditions are necessary for removing interfering substances and reducing the sample complexity of IVD. We compared 5 different buffers such as 1X laemelli, 2% SDS, guanidium-HCl, Tris-acetate NaCl, and RIPA and found that sequential extraction using radio RIPA buffer followed by 2% SDS resulted in the maximum yield of proteins. Further, minimal protein loss during sample clean-up is of paramount importance to enhance the sensitivity and scalability of protein identification. We used the following agents’ acetone; ethanol; TCA-acetone; 3-kDa membrane cutoff device and methanolchloroform; and out of these, methanol-chloroform was found to be efficient in terms of removal of glycans, salts and detergents, and recovery of total proteins. Another interesting observation was the contribution of many uncharacterized proteins and cDNA fragments to nearly 6% of the total proteins identified in the samples before the clean-up, signifying the necessity for sample clean-up process to remove such proteins.
3. Validation of the NP Phenotype
To validate the proteomic characterization of the normal NP, we employed a candidate approach for NP associated genes previously identified by transcriptome, microarray, immunolocalization, proteomics analysis of bovine [6], murine [7], canine [8], and human disc tissues [14,17,20,21]. Out of 31 reported candidate genes, 15 were found in our study. Similar to other molecular studies on human NP using various platforms, our proteomics analysis also identified well-characterized core matrisome proteins such as ACAN (aggrecan), COL12A1 (collagen 12A1), DCN (decorin), LUM (lumican), ANXA3 (annexin), A2M (alpha 2 macroglobulin), and intracellular proteins such as Keratins-KRT19, KRT18, KRT8, VIM (vimentin), and DSC2 (desmocollin-2). These findings validate our study on control NP and demonstrate its normalcy.
4. Proteomic Signature of Adult Human IVD
The proteome of NP was characterized by the presence of 1,116 proteins with 57% of matrisomal proteins (core matrisome, regulators, ECM affiliated, and secreted factors) and 43% of other proteins (cytoskeletal proteins, intracellular proteins, membrane proteins, and blood components). Among the 1,116 proteins, 242 proteins with a PSM > 5 were subjected to GO analysis, which revealed that the majority of these proteins were involved in ECM organization. These proteins were mainly concentrated in the ECM, followed by the membrane and cytoplasmic regions. Further, 105 significant pathways representing mechanisms of IVD homeostasis was identified. Among these pathways, it was surprising to see that the maximum number of proteins were involved in the immune system (57 proteins) and innate immune system (45 proteins) followed by 37 proteins involved in ECM organization and Development Biology. Based on enrichment (p-values), the most significant pathway was the formation of cornified envelope followed by ECM organization and platelet degranulation. Further, the core matrisome groups of glycoproteins, proteoglycans, and collagens were involved in integrin cell surface interaction-pathway, which is believed to play a significant role in maintaining cellular homeostasis by mediating the cross-talk mechanisms between intracellular and extracellular region. Another interesting finding was that among the clusters of proteins that form tight interactions with each other, apart from collagens, glycoproteins and proteoglycans, SERPINs, and keratins were also found.
5. Collagens
Collagen 1 and 2 are the most discussed collagens in IVD, and in our study, 14 Collagen types-1, -2, -5, -6, -7, -8, -9, -10, -11, -14, -15, -18, -20, and -24 were identified in the NP. Collagen 2 is believed to be the main constituent in NP, which forms a fibrillary network and helps in aggregating proteoglycan to provide tensile strength [22]. Collagen types-3, -6, -9, and -11 have also been reported to contribute to disc homeostasis [23]. Apart from cell adhesion and cross bridging, collagen 3 are believed to be associated with collagen 6. Collagen 6 forms chondrons and fibrous capsules that can encapsulate cells and have got cytoprotective effect by counteracting apoptosis and oxidative damage. While collagen 9 cross-links to collagen 2 and regulates its size, collagen 11 plays a vital role in maintaining the spacing and width of type 2 collagen. However, the role of collagen types-18, -20, and -24 in IVD remains unknown and needs further research. The presence of 14 types of collagen in the NP of human IVD has never been reported before and it could be that though collagen 2 constitutes the most of NP, the regulatory and supporting roles of other collagens might be very crucial for the survival and functioning of other molecules and has been neglected by most researchers.
6. Glycoproteins
Among the highly ranked proteins, which formed a cluster, some of the notable glycoproteins which formed tight interaction with other proteins include: FN1 (fibronectin), THBS1 (thrombospondin-1), EFEMP1 (epidermal growth factor-containing fibulin-like extracellular matrix protein-1), VTN, MTN2 (matrilin-2), MTN4 (matrilin-4), MMRN1 (multimerin-1), TGFB1 (transforming growth factor beta-1), and TNC (tenascin-C). FN1 is a normal constituent of ECM known to bind collagen molecules and has an immense role in cell adhesion and cell motility. The upregulation of FN1 has been associated with aging and DDD in previous studies [24]. On the other hand, downregulation of THBS1 is associated with DDD. Matrilins are essential adhesive glycoproteins for maintaining the ECM volume and also are believed to have regenerative potential [25]. Multimerin is another adhesive glycoprotein that is soluble and has been reported to be present in endothelial cells, with its role in IVD unknown [26]. EFEMP1 also known as fibulin-3 is an essential modulator of ECM as it upregulates the expression of tissue inhibitor of metalloproteinase (TIMP)-1 & 3, thereby inhibiting the expression of MMP-2, MMP-3, and MMP-9 [27]. Similarly, TGFB1 stimulates the ECM precursors and has excellent potential in tissue regeneration. TNC has immense anti-inflammatory, and antiangiogenic properties and its downregulation have been associated with aging, and DDD [28]. Vitronectin is an essential ECM glycoprotein, which binds to integrin and thus promotes cell adhesion [29]. A quantitative proteomic study estimating the expression of these molecules is critical to understand their role in aging and DDD. Apart from their role in the maintenance of ECM, a majority of glycoproteins also have metabolic and functional properties.
7. Proteoglycans
OMD (osteomodulin), FMOD, ASPN (asporin), BGN (biglycan), DCN, PRELP (prolargin), OGN (osteoglycin), LUM, and chondroadherin (CHAD) formed significant interactions among the proteoglycans. These molecules belong to a family of proteins called small leucine-rich proteoglycans (SLRPs), which have been implicated in IVD homeostasis, and DDD [30]. FMOD and LUM are close homologs, and while the accumulation of FMOD is related to aging and DDD, an abundance of LUM indicates healthy IVD. DCN and BGN are closely associated with each other and are believed to have a significant role in fetal development and its regulation. Apart from interacting with collagens, DCN, BGN, FMOD, and LUM also regulate growth factors such as TGFB and fragmentation of these SLRPs, induce an inflammatory state, and initiate the degradative process. The upregulation of ASPN negatively regulates the expression of collagen 2 and Aggrecan by inhibiting TGFB and is associated with IVD degeneration [31].
8. Serine Protease Inhibitors
Twelve different types of SERPINs identified were found to interact with each other in our study. Some of the SERPINs such as SERPINA1, A3, and E2 have been studied in vivo and in vitro in disc disease. Neutrophil elastase is a critical regulatory molecule in degenerative and inflammatory diseases through its active involvement in proteolysis of elastin and collagen-IV of ECM. SERPINA1, which is one of the top-ranked proteins in our PPI analysis, plays a vital role in inhibiting neutrophil elastase and thereby is essential to inhibit a catabolic cascade of events [32]. While SERPINE2 inhibits the extracellular proteases via the internalization process [33], SERPINA3 inhibits a pro-inflammatory enzyme called neutrophil cathepsin G and helps in limiting ECM remodeling, coagulation, apoptosis, and inflammatory process [34]. The expression and function of other SERPINs and their correlation in normal IVD need to be elaborated with more experimental evidence to understand its role in the maintenance of normal homeostasis.
9. Cytoskeletal Proteins
Besides SERPINs, tight interactions were noted between the intermediate filament keratins, which are one of the 3 major cytoskeletal assemblies in higher organisms [35]. Intermediate filament network play a crucial role in the spatial organization of microtubules and microfilaments or both. Keratins are responsible for cellular homeostasis, resistance to stress response exerted by mechanical and nonmechanical factors, cellular integrity, growth, and survival. Expression of KRT 8 and KRT 18, a member of intermediate filament assembly, which exerts resistance towards multiple mechanical or toxic mediated stress responses, in our study serves as a proof of concept for disc homeostasis. VMN is a cytoskeletal protein, and it was found to be interacting with KRT8 in our study. VIM is known for several cellular functions and significant physiological changes during development and its loss is associated with DDD [36]. KRT 19, which is considered as an NP marker, was also found in our study, which assures that the samples we have used are representative of normal IVD.
10. Can Discs Harvested From Scoliosis and Lumbar Burst Fractures Be Considered Controls?
We compared our proteomic data with that of studies which have used discs from lumbar burst fractures [21] and scoliosis [20]. This analysis showed only 60 proteins common to the scoliosis group and our research compared to 51 proteins common between the lumbar burst fracture study group and our research, indicating the vast difference in both their physiological states despite appearing normal in MRI.
On analyzing the unique proteins of lumbar burst fracture disc group, it was interesting to note the presence of proteins such as HECTD1 (HECT domain E3 ubiquitin-protein ligase 1), ANKRD12 (ankyrin repeat domain 12), UBR4 (ubiquitinprotein ligase E3 component n-recognin 4), and LTN1 (listerin E3 ubiquitin-protein ligase 1) participating in either one of the processes such as class I major histocompatibility complex mediated antigen processing, antigen-presenting, and ubiquitination, which are catabolic degradative pathways mediated by the ubiquitin-proteasome complex. The upregulation of degenerative pathways in these MRI normal discs may be secondary to the traumatic molecular changes such as edema, bleeding, and endplate disruption occurring adjacent to the burst fractures. Besides, ubiquitin-mediated degradation has been reported as a very typical observation in our previous study indicating the rapid deterioration of the IVD intracellular proteins. Taken together, this illustrates that discs adjacent to LBF cannot be considered as true biological controls and studies treating them as controls will fail in biomarker discovery in DDD.
Similarly, the unique proteins from scoliotic discs such as AHSG (alpha 2-HS glycoprotein), DERA (deoxyribose phosphate aldolase), ORM1 (alpha-1-acid glycoprotein 1 precursor), PPBP (platelet basic protein precursor), VNN1 (pantetheinase precursor, vanin), PKM2 (pyruvate kinase), POTEKP (putative beta-actin-like protein 3) participate in platelet degranulation & neutrophil degranulation. Besides, the presence of proteins such as; ORM1, which is known to play a significant role in acute phase inflammation; DERA, a protein highly responsible for stress-induced damage by producing energy through deoxy nucleoside degradation and VNN1, an inducer of oxidativestress response, clearly indicates the inflammatory response to the abnormal stress induced by asymmetric physical loads in these scoliotic discs. Therefore, these scoliotic discs are far from being considered normal discs and thus being an abysmal control; they cannot be used for comparative studies for defining the pathological states of degenerate human IVD.
Further, it is not surprising that most of the basic science research is being conducted in animal models, and regenerative therapies for DDD are under trial for their possible implications in humans. However, the basic requirement of this translational research is the need for animal tissues to resemble that of humans. However, from our analysis, it is evident that the proteome of the normal IVD of humans differs immensely from that of animal models such as bovine, murine, and canine discs. The extrapolation of results from molecular studies done in animals to solve human pathologies should be done with extreme caution considering the above facts.
11. Implications
To summarise, this study has defined the proteomic signature of human IVD for the first time by analyzing the MRI normal discs harvested from brain dead yet alive voluntary organ donors. These discs represent true biological controls, unlike discs harvested from patients with scoliosis and trauma, and therefore are ideal for comparative proteomics studies and biomarker discovery. Two essential steps for maximal identification of proteins from IVD, viz. sequential extraction using RIPA and 2% SDS followed by sample clean-up have been discussed. The various proteins, their BPs, along with pathways that play a significant role in disc homeostasis, have been enlisted. Through immunohistochemistry, we have validated the localization & expression of a subset of IVD proteins. Further, apart from collagens, proteoglycans, and glycoproteins, the importance of SERPINs and Keratins in maintaining disc homeostasis has been highlighted which needs further research to understand their regulatory mechanisms and involvement in disc degeneration.
12. Limitations
Only 9 IVDs were available for analysis at the time of this study. However, it is acceptable considering the rarity of MRI normal discs from voluntary organ donors. A comparison of proteins derived from our research with earlier reports might not be ideal as they vary in methodology. However, the total number of proteins identified in this study is much higher than the previously reported ones and it is highly unlikely that our data can miss out on the proteins considered unique to the other groups. A detailed description of all the proteins and pathways is beyond the scope of this study, and each of these proteins has to analyzed individually for their role in health and disease.
CONCLUSION
We identified a total of 1,116 proteins in our study, which accounts to be the highest number of proteins reported in human IVD so far. The samples obtained from brain dead organ donors can be described as a biologically normal NP, whose cellular mechanism reflects the ideal scenario of a healthy disc. In comparison, the upregulations of inflammatory and degradative pathways in scoliosis and lumbar burst fracture discs, respectively, imply that these previously used controls are far from ideal controls. The methodology used in the analysis of the proteome also captures proteins involved in ECM homeostasis, which has not been reported until now in healthy NP.
Acknowledgments
We received funding from Ganga Orthopedic Research and Education Foundation (GOREF-2-2017). We thank Ms. Alishya Maria Jose for her help in sample collection and data maintenance and Ms. Sujitha M of Aravind Medical Research Foundation for LC-MS/MS acquisitions.
Footnotes
The authors have nothing to disclose.
SUPPLEMENTARY MATERIALS
Supplementary materials can be found via https://doi.org/10.14245/ns.2040056.028.
REFERENCES
- 1.Hartvigsen J, Hancock MJ, Kongsted A, et al. What low back pain is and why we need to pay attention. Lancet. 2018;391:2356–67. doi: 10.1016/S0140-6736(18)30480-X. [DOI] [PubMed] [Google Scholar]
- 2.Meir AR, Fairbank JC, Jones DA, et al. High pressures and asymmetrical stresses in the scoliotic disc in the absence of muscle loading. Scoliosis. 2007;2:4. doi: 10.1186/1748-7161-2-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Stokes IA, Burwell RG, Dangerfield PH, et al. Biomechanical spinal growth modulation and progressive adolescent scoliosis-a test of the ‘vicious cycle’ pathogenetic hypothesis: summary of an electronic focus group debate of the IBSE. Scoliosis. 2006;1:16. doi: 10.1186/1748-7161-1-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sander AL, Laurer H, Lehnert T, et al. A clinically useful classification of traumatic intervertebral disk lesions. AJR Am J Roentgenol. 2013;200:618–23. doi: 10.2214/AJR.12.8748. [DOI] [PubMed] [Google Scholar]
- 5.Haschtmann D, Stoyanov JV, Gédet P, et al. Vertebral endplate trauma induces disc cell apoptosis and promotes organ degeneration in vitro. Eur Spine J. 2008;17:289–99. doi: 10.1007/s00586-007-0509-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Caldeira J, Santa C, Osório H, et al. Matrisome profiling during intervertebral disc development and ageing. Sci Rep. 2017;7:11629. doi: 10.1038/s41598-017-11960-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.McCann MR, Patel P, Frimpong A, et al. Proteomic signature of the murine intervertebral disc. PLoS One. 2015;10:e0117807. doi: 10.1371/journal.pone.0117807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Erwin WM, DeSouza L, Funabashi M, et al. The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc. Arthritis Res Ther. 2015;17:240. doi: 10.1186/s13075-015-0733-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zybailov B, Mosley AL, Sardiu ME, et al. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res. 2006;5:2339–47. doi: 10.1021/pr060161n. [DOI] [PubMed] [Google Scholar]
- 10.Jeong H, Mason SP, Barabási AL, et al. Lethality and centrality in protein networks. Nature. 2001;411:41–2. doi: 10.1038/35075138. [DOI] [PubMed] [Google Scholar]
- 11.Sive JI, Baird P, Jeziorsk M, et al. Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol. 2002;55:91–7. doi: 10.1136/mp.55.2.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Pattappa G, Li Z, Peroglio M, et al. Diversity of intervertebral disc cells: phenotype and function. J Anat. 2012;221:480–96. doi: 10.1111/j.1469-7580.2012.01521.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lee CR, Sakai D, Nakai T, et al. A phenotypic comparison of intervertebral disc and articular cartilage cells in the rat. Eur Spine J. 2007;16:2174–85. doi: 10.1007/s00586-007-0475-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Minogue BM, Richardson SM, Zeef LA, et al. Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Res Ther. 2010;12:R22. doi: 10.1186/ar2929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sakai D, Nakai T, Mochida J, et al. Differential phenotype of intervertebral disc cells: microarray and immunohistochemical analysis of canine nucleus pulposus and anulus fibrosus. Spine (Phila Pa 1976) 2009;34:1448–56. doi: 10.1097/BRS.0b013e3181a55705. [DOI] [PubMed] [Google Scholar]
- 16.Rodrigues-Pinto R, Richardson SM, Hoyland JA. Identification of novel nucleus pulposus markers: interspecies variations and implications for cell-based therapiesfor intervertebral disc degeneration. Bone Joint Res. 2013;2:169–78. doi: 10.1302/2046-3758.28.2000184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Richardson SM, Ludwinski FE, Gnanalingham KK, et al. Notochordal and nucleus pulposus marker expression is maintained by sub-populations of adult human nucleus pulposus cells through aging and degeneration. Sci Rep. 2017;7:1501. doi: 10.1038/s41598-017-01567-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Fujita N, Miyamoto T, Imai J, et al. CD24 is expressed specifically in the nucleus pulposus of intervertebral discs. Biochem Biophys Res Commun. 2005;338:1890–6. doi: 10.1016/j.bbrc.2005.10.166. [DOI] [PubMed] [Google Scholar]
- 19.Tang X, Jing L, Chen J. Changes in the molecular phenotype of nucleus pulposus cells with intervertebral disc aging. PLoS One. 2012;7:e52020. doi: 10.1371/journal.pone.0052020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Sarath Babu N, Krishnan S, Brahmendra Swamy CV, et al. Quantitative proteomic analysis of normal and degenerated human intervertebral disc. Spine J. 2016;16:989–1000. doi: 10.1016/j.spinee.2016.03.051. [DOI] [PubMed] [Google Scholar]
- 21.Yee A, Lam MP, Tam V, et al. Fibrotic-like changes in degenerate human intervertebral discs revealed by quantitative proteomic analysis. Osteoarthritis Cartilage. 2016;24:503–13. doi: 10.1016/j.joca.2015.09.020. [DOI] [PubMed] [Google Scholar]
- 22.Lian C, Gao B, Wu Z, et al. Collagen type II is downregulated in the degenerative nucleus pulposus and contributes to the degeneration and apoptosis of human nucleus pulposus cells. Mol Med Rep. 2017;16:4730–6. doi: 10.3892/mmr.2017.7178. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Galbusera F, Wilke HJ. The mechanical role of collagen fibers in the intervertebral disc. In: Sharabi M, Wade K, HajAli R, editors. Biomechanics of the spine: basic concepts, spinal disorders and treatments. London: Academic Press; 2018. pp. 105–23. [Google Scholar]
- 24.Greg Anderson D, Li X, Tannoury T, et al. A fibronectin fragment stimulates intervertebral disc degeneration in vivo. Spine (Phila Pa 1976) 2003;28:2338–45. doi: 10.1097/01.BRS.0000096943.27853.BC. [DOI] [PubMed] [Google Scholar]
- 25.Malin D, Sonnenberg-Riethmacher E, Guseva D, et al. The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. J Cell Sci. 2009;122(Pt 7):995–1004. doi: 10.1242/jcs.040378. [DOI] [PubMed] [Google Scholar]
- 26.Hayward CP, Cramer EM, Song Z, et al. Studies of multimerin in human endothelial cells. Blood. 1998;91:1304–17. [PubMed] [Google Scholar]
- 27.Lin Z, Wang Z, Li G, et al. Fibulin-3 may improve vascular health through inhibition of MMP-2/9 and oxidative stress in spontaneously hypertensive rats. Mol Med Rep. 2016;13:3805–12. doi: 10.3892/mmr.2016.5036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Gruber HE, Ingram JA, Hanley EN., Jr Tenascin in the human intervertebral disc: alterations with aging and disc degeneration. Biotech Histochem. 2002;77:37–41. [PubMed] [Google Scholar]
- 29.Wikipedia Vitronectin [Internet] 2019 [cited 2020 Jan 31]. Available from: https://en.wikipedia.org/w/index.php?title=Vitronectin&oldid=887410367.
- 30.Brown S, Melrose J, Caterson B, et al. A comparative evaluation of the small leucine-rich proteoglycans of pathological human intervertebral discs. Eur Spine J. 2012;21 Suppl 2:S154–9. doi: 10.1007/s00586-012-2179-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wang S, Liu C, Sun Z, et al. IL-1β increases asporin expression via the NF-κB p65 pathway in nucleus pulposus cells during intervertebral disc degeneration. Sci Rep. 2017;7:4112. doi: 10.1038/s41598-017-04384-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Morris CA, Pani AM, Mervis CB, et al. Alpha 1 antitrypsin deficiency alleles are associated with joint dislocation and scoliosis in Williams syndrome. Am J Med Genet C Semin Med Genet. 2010;154C:299–306. doi: 10.1002/ajmg.c.30265. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Low DA, Baker JB, Koonce WC, et al. Released proteasenexin regulates cellular binding, internalization, and degradation of serine proteases. Proc Natl Acad Sci U S A. 1981;78:2340–4. doi: 10.1073/pnas.78.4.2340. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Chelbi ST, Wilson ML, Veillard AC, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet. 2012;21:1968–78. doi: 10.1093/hmg/dds006. [DOI] [PubMed] [Google Scholar]
- 35.Jacob JT, Coulombe PA, Kwan R, et al. Types I and II Keratin Intermediate Filaments. Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):pii: a018275. doi: 10.1101/cshperspect.a018275. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Ivaska J, Pallari HM, Nevo J, et al. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res. 2007;313:2050–62. doi: 10.1016/j.yexcr.2007.03.040. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.